Development of Anxiety in early Parkinson’s Disease: A clinical and biomarker study

Development of Anxiety in early Parkinson’s Disease: A clinical and biomarker study
Eur J Neurol. 2023 May 25. doi: 10.1111/ene.15890. Online ahead of print.ABSTRACTBACKGROUND: Anxiety affects approximately 40% of Parkinson's disease (PD) patients. However, little is known about its predictors and development over time.OBJECTIVE: to identify the clinical factors and biomarkers associated with development of anxiety in patients with newly diagnosed PD, and to test which risk factors predict increases in anxiety ... read more
Source: PubMedPublished on 2023-05-25By Hanyuying Wang